Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Cash from Discontinued Operations (2022)

Updated

Regenerative Medical Technology's Cash from Discontinued Operations came in at $69,463 for Q4 2022.

Analysis

Regenerative Medical Technology (RMTG) Cash from Discontinued Operations (2022) Analysis & Trends

For FY2022, Regenerative Medical Technology's Cash from Discontinued Operations was $69,713.

  • Going back by year, Cash from Discontinued Operations was -$13,207 in FY2021.
  • Business Quant data shows RMTG's Cash from Discontinued Operations at -$234.00 (Q3 2022), $408.00 (Q2 2022) and $76.00 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 69,463.00
Sep 30, 2022 -234.00
Jun 30, 2022 408.00
Mar 31, 2022 76.00
API Access

Regenerative Medical Technology Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=RMTG&period=max&api_key=YOUR_API_KEY